Joel C. Thompson

发表

Cardiovascular , Pulmonary , and Renal Pathology Renal Accumulation of Biglycan and Lipid Retention Accelerates Diabetic Nephropathy

L. Schaefer, Lisa R Tannock, Joel C. Thompson, 2011 .

Decreased Body Fat, Elevated Plasma Transforming Growth Factor-β Levels, and Impaired BMP4-Like Signaling in Biglycan-Deficient Mice

K. Williams, C. Nelson, T. Tang, 2013, Connective tissue research.

PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice

David E. Hall, K. Rayner, N. Mackman, 2018, Arteriosclerosis, thrombosis, and vascular biology.

Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development11 This work was presented in part at the Arteriosclerosis, Thrombosis, and Vascular Biology annual conference, Denver, CO, 2006. Published, JLR Papers in Press, November 21, 2007.

J. Rutledge, H. Aung, Lisa R Tannock, 2008, Journal of Lipid Research.

Elevated circulating TGF-β is not the cause of increased atherosclerosis development in biglycan deficient mice.

Lisa R Tannock, Joel C. Thompson, Patricia G. Wilson, 2018, Atherosclerosis.

Increased atherosclerosis in mice with increased vascular biglycan content.

T. Tang, Lisa R Tannock, Joel C. Thompson, 2014, Atherosclerosis.

Prevention of TGFβ induction attenuates angII-stimulated vascular biglycan and atherosclerosis in Ldlr−/− mice1[S]

C. Nelson, T. Tang, Lisa R Tannock, 2013, Journal of Lipid Research.

Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-β inhibition[S]

R. Charnigo, Lisa R Tannock, Joel C. Thompson, 2017, Journal of Lipid Research.

Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice1

L. Schaefer, Lisa R Tannock, Joel C. Thompson, 2010, Journal of Lipid Research.

Deficiency of Angiotensinogen in Hepatocytes Markedly Decreases Blood Pressure in Lean and Obese Male Mice

R. Charnigo, L. Cassis, Nika Larian, 2015, Hypertension.

Adipocyte (Pro)Renin-Receptor Deficiency Induces Lipodystrophy, Liver Steatosis and Increases Blood Pressure in Male Mice

G. Nguyen, M. Gong, Joel C. Thompson, 2016, Hypertension.

Serum Amyloid A Is an Exchangeable Apolipoprotein

P. McNamara, P. Shridas, N. Webb, 2018, Arteriosclerosis, thrombosis, and vascular biology.

Serum amyloid A in atherosclerosis

V. King, Lisa R Tannock, Joel C. Thompson, 2011, Current opinion in lipidology.

Serum amyloid A3 is pro-atherogenic.

P. Shridas, N. Webb, F. D. de Beer, 2018, Atherosclerosis.

Biglycan deficiency: increased aortic aneurysm formation and lack of atheroprotection.

J. Fischer, K. Williams, T. Tang, 2014, Journal of molecular and cellular cardiology.

Collaborative team dynamics and scholarly outcomes of multidisciplinary research teams: A mixed-methods approach

R. DiPaola, H. Surratt, P. Kern, 2023, Journal of Clinical and Translational Science.

A brief elevation of serum amyloid A is sufficient to increase atherosclerosis[S]

N. Webb, Lisa R Tannock, Joel C. Thompson, 2015, Journal of Lipid Research.

Prioritizing studies of COVID-19 and lessons learned

Denise H. Daudelin, A. Cameron, Alyssa B. Cabrera, 2021, Journal of Clinical and Translational Science.

Deficiency of Endogenous Acute Phase Serum Amyloid A Does Not Affect Atherosclerotic Lesions in Apolipoprotein E–Deficient Mice

A. Daugherty, D. Rateri, Deborah A. Howatt, 2014, Arteriosclerosis, thrombosis, and vascular biology.

Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner.

V. King, N. Webb, F. D. de Beer, 2008, The American journal of pathology.

Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy.

Lisa R Tannock, Joel C. Thompson, Patricia G. Wilson, 2011, The American journal of pathology.

Serum amyloid A in atherosclerosis

V. King, Lisa R Tannock, Joel C. Thompson, 2011, Current opinion in lipidology.